ArticleBMC public health2025
Epidemiological patterns of cutaneous leishmaniasis in north-west Pakistan (2022-2023).
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cutaneous leishmaniasis: emerging insights in epidemiology, diagnosis, and treatment.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCutaneous Leishmaniasis (CL), the most prevalent type of Leishmaniasis, is a significant public health problem in various regions of the world including Pakistan, resulting in huge morbidity and social stigmatization.
methodsThis retrospective study was carried out mainly in three districts: Bajaur, Malakand and Dir Lower of Khyber Pakhtunkhwa (KP), Pakistan. Additionally, some cases from other districts were also recorded. Patients of different localities and age groups visiting healthcare centers including District Headquarters Hospitals in Dargai, Malakand and Bajaur were included in the study, with the approval from District Health Officer (DHO) of concerned districts.
resultsIn total, 2035 cases of CL were recorded during the study period from January 2022 to February 2023. Statistical analysis revealed that the disease predominantly affected patients under 20 years of age (n = 1259, 61.9%), particularly males (n = 1067, 52.5%). The proportion of facial lesions was predominant (n = 1145, 56.3%), followed by lesions on the upper extremities (n = 317, 15.6%) and lower extremities (n = 338, 16.6%). Our findings indicate a high prevalence of CL in district Bajaur (n = 1222, 60.04%), followed by Malakand (n = 587, 28.84%) and Dir Lower (n = 153, 7.52%). Peak cases were recorded during summer and spring whereas autumn and winter showed a relatively lower incidence of CL, likely due to harsh environmental conditions that reduce the survival of sandflies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.